CliffBio
small molecule

VUMERITY

DIROXIMEL FUMARATE

Loss of exclusivityOctober 2033latest FDA-listed patent expiry
CompanyBiogen →See this company's full patent-cliff portfolio

Drug detail

Brand nameVUMERITY
Active ingredientDIROXIMEL FUMARATE
Strength231MG
Dosage formCAPSULE, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2019
Marketing statusRX

Listed patents

PatentExpiresType
8669281October 2033substance, product
9090558September 2033use U-1384
10080733September 2033substance, product

More from Biogen

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

VUMERITY patent cliff — loss of exclusivity October 2033 | CliffBio